$9.3M sweet spot round size
Most of their 10 investments are in rounds between $3.3M and $22M
2012
Peptomyc raised $3.3M on January 18, 2022
Investors: Alta Life Sciences and Healthequity, SCR
Peptomyc raised $14M on December 15, 2020
Investors: AurorA Science, Alta Life Sciences, CDTI, Centre for the Development of Industrial Technology and Healthequity, SCR
Versantis AG raised $16M on September 18, 2019
Investors: Redalpine, Zürcher Kantonalbank and Healthequity, SCR
Undisclosed raised $63M on June 26, 2019
Investors: Alta Life Sciences, Lundbeckfonden / Lundbeck Foundation, COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Andera Partners, Ysios Capital, Forbion, Gilde Healthcare and Healthequity, SCR
Versantis AG raised $4.4M on March 29, 2017
Investors: Altus Capital Partners, OCCIDENT, Redalpine, Zürcher Kantonalbank and Healthequity, SCR
Peptomyc raised $1.1M on April 27, 2016
Investors: Healthequity, SCR
Minoryx Therapeutics raised $22M on October 14, 2015
Investors: Chiesi Ventures, Idinvest Partners, Ysios Capital and Healthequity, SCR
Undisclosed raised $41M on September 8, 2015
Investors: Lundbeckfonden / Lundbeck Foundation, Ysios Capital, Fundación Bancaria ”la Caixa”, Forbion, Andera Partners, Gilde Healthcare and Healthequity, SCR
Minoryx Therapeutics raised $808K on April 9, 2015
Investors: Healthequity, SCR
Undisclosed raised $4.8M on August 21, 2014
Investors: Healthequity, SCR